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ABSTRACT
Surgery is the recommended treatment modal-
ity for primary breast cancer. Breast cancer sur-
gery is non-visceral; therefore, it is often
assumed that the subsequent impact on func-
tional status in older women is less significant
compared to other cancer types such as col-
orectal cancer. Evidence for this however, is
lacking. The definition of functional status
varies amongst healthcare professionals and
patients, making comparisons between studies
difficult. From the literature, the two most
common themes in relation to functional status
following breast cancer surgery are activities of
daily living and quality of life. Both of these
elements of functional status are adversely
impacted in patients following breast cancer
surgery. A more significant decline is seen in
patients with pre-existing comorbidities and
with greater intensity of surgery, which
includes more invasive breast and/or axillary
surgery as well as additional reconstructive
procedures. Identifying and optimising pre-ex-
isting factors which may predict post-operative
decline in functional status, such as cognitive
impairment and deteriorating functional
decline over the preceding year, may help in
reducing deterioration in functional status after
breast cancer surgery. Methods which may be
employed to detect and optimise these factors
include geriatric assessment and exercise
intervention.
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Breast cancer surgery is assumed to have
minimal impact on the functional status
of older women compared to other types
of cancer surgery, for example, for intra-
abdominal cancers.
There is evidence of a deterioration in the
ability to perform activities of daily living
and quality of life after breast cancer
surgery in older women.
The level of deterioration is associated
with pre-existing comorbidities and
greater intensity of the surgical procedure.
As healthcare professionals, we must
identify possible risk factors for decline in
functional status pre-operatively and have
frank discussions with our patients about
how we can most appropriately deal with
these and the possibility of irreversible
decline.
INTRODUCTION
Breast cancer is the most common malignancy
in women worldwide, and its incidence is
increasing. This is partly due to our aging pop-
ulation and the improvement in management
of co-existing comorbidities in older patients.
Surgery is the recommended treatment option
for primary breast cancer irrespective of age.
Primary endocrine therapy (PET) may be an
alternative in selected older patients with sig-
nificant comorbidities, as the overall survival
benefit observed with surgery in certain sub-
types of breast cancer may prove to be minimal
when life expectancy is limited by other
comorbidities [1, 2]. Furthermore, a survey
involving surgical oncologists published by
Ghignone et al. [3] highlighted that quality of
life (QOL) and recovery of functional status (FS)
were considered the most pertinent outcomes
in onco-geriatric surgery, rather than overall
survival.
The National Audit of Breast Cancer in Older
Patients (NABCOP) 2020 annual report [4]
described some key findings on how breast
cancer management differed between older and
younger women in England and Wales. It was
noted that the proportion of women undergo-
ing surgery for early invasive breast cancer
decreased with increasing age, from 96% (age
50–69) to 75% (age 70?) within the first year of
diagnosis. Furthermore, this decrease was
reported to be more marked in older patients
with oestrogen receptor-positive (ER?) breast
cancer, likely due to the option of PET as a
treatment alternative.
Baseline level of functioning should be con-
sidered when weighing up the risks and benefits
of surgery for breast cancer, as it may serve to
predict poor post-operative QOL outcomes [5].
Functional status refers to an individual’s
physical and cognitive capability to perform
their usual activities of daily living (ADL),
allowing for the maintenance of personal
health and well-being [5–9]; however, this def-
inition is quite broad, and actual domains of FS
can vary between users. Commonly considered
domains include physical and psychological
functioning, cognition, social activity and
independence with ADLs [6, 9]. The impact of
surgery on FS is better documented in cases of
colorectal cancer [8], whereas comparatively
less is known about the effects of breast cancer
surgery. It is hypothesised that because breast
cancer surgery is non-visceral, its subsequent
impact on functional decline may be less sub-
stantial; however, in part due to this assump-
tion, there is limited evidence on the topic.
In this article we examine current evidence
looking at FS after breast cancer surgery in older
patients, in the most commonly reported
domains—ADLs and QOL. We then discuss how
pre-existing patient factors may predict post-
operative decline in FS. Next, we outline two
current prospective studies in the UK focusing
on FS, and possible future directions for inter-
ventions in this field including geriatric assess-
ment and exercise intervention.
This article is based on previously conducted
studies and does not contain any new studies
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with human participants or animals performed
by any of the authors. Ethical approval was not
required.
A summary of the key findings in each of
these areas is presented in Table 1.
EFFECTS OF BREAST CANCER
SURGERY ON FUNCTIONAL STATUS
OUTCOMES
Several studies [5–11] have reported the nega-
tive impact of elective cancer treatment on
subsequent FS trajectories by examining how it
affects the broad areas of ADL and QOL.
Activities of Daily Living
An observational study by Tang et al. [9] studied
the impact of different types of breast cancer
surgery on FS and survival amongst 5969 nurs-
ing home residents aged C 67 years (mean age
82) using the Minimum Data Set for Nursing
Home Activities of Daily Living summary score
(MDS-ADL). This is scored between 0 and 28, 0
indicating independence and 28 indicating
total dependence in all measured activities. Of
the residents, 55–60% exhibited functional
decline at 1 year post-surgery, with an average
drop in MDS-ADL score of 2.8 points following
lumpectomy, 4.1 points after mastectomy and
4.6 points post-axillary lymph node dissection
(ALND). In support of this, Singh et al. [5]
showed that bilateral mastectomies in 314 older
Appalachian women aged C 65 years were
associated with poorer functional preservation
(p = 0.03) when compared to patients who
underwent a unilateral mastectomy or lumpec-
tomy, demonstrating the more apparent decline
in FS outcomes after more extensive surgery. A
systematic review on the subject [6], which
included 10 studies, further summarised how
patients post-ALND experienced appreciable
impairment in their autonomy in carrying out
their ADLs.
A prospective cohort study by Abbema et al.
[12] examined the impact of age, cancer diag-
nosis and treatment on FS decline in older
patients with breast and colorectal cancers. This
was achieved by looking at two age groups with
cancer who had undergone surgery; 179
patients aged C 70 and 341 patients aged 50–69
were compared. In addition, 317 participants
aged C 70 without cancer were included as a
control group. Functional status was assessed at
baseline and at 12 months using the Katz ADL
scale, scored 0–6 (0, unable to perform any
activity; 6, able to perform all activities) and the
Lawton instrumental ADL (IADL) scale, scored
0–5 and 0–8 for men and women, respectively
(0, unable to perform any activity; 5 and 8, able
to perform all activities). Results demonstrated
that there was a decline in ADL and IADL of
16.7% and 12.6%, respectively, for younger
cancer patients, compared to 26.8% and 31.3%,
respectively, in older cancer patients and 16.7%
and 17.4%, respectively, in older participants
without cancer. Overall FS deterioration in
younger and older cancer patients was 24.6%
and 43.6%, respectively, with a 28.1% decline
in older non-cancer participants [12].
These studies outline how breast cancer sur-
gery has a measurable negative impact on the
independence of older patients in carrying out
their ADLs. This deterioration in FS appears to
be more apparent in patients undergoing more
extensive surgery. Therefore, treatment plans
should be individualised accordingly to pre-
serve post-operative FS where possible.
Quality of Life
A longitudinal cohort study by Mandeblatt et al.
[10] assessed different domains of QOL out-
comes post-ALND in 571 patients
aged C 67 years using the 12-Item Short Form
Survey (SF-12). It was noted that long-term arm
problems (defined as swelling or limitation in
arm, hand or finger movements) post-breast
cancer surgery were the main determinants for
reductions in both physical (p = 0.0001) and
mental (p = 0.04) performance. This study
reported that 60% of patients, of which 83%
underwent axillary surgery, demonstrated
impaired arm functioning at 2 years. Pre-exist-
ing arthritis was another notable predictor of
long-term arm symptoms and showed a multi-
plicative effect in women who also underwent
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Table 1 A summary of the findings of studies examining the effect of breast cancer surgery on functional status outcomes in
older women
Current evidence
Effects of breast cancer surgery on
FS outcomes
Activities of daily living
Functional decline is noted after breast cancer surgery and is more apparent after
extensive surgery [5, 9]
Cancer diagnosis and treatment, along with older age, are important predictors of
decline in both ADL and IADL [12]
Quality of life
Long-term arm problems post-breast cancer surgery disrupted upper body function
and were the main determinants for reductions in both physical and mental
performance [9, 10]
Following post-mastectomy reconstruction, older patients (65–77 years) showed
poorer outcomes in physical function compared to younger patients (25–64 years),
but demonstrated better social functioning and mental health outcomes [11]
Pre-existing factors influencing FS
outcomes
Pre-existing patient factors such as advanced age, multiple comorbidities, obesity, lower
educational attainment and smoking are possible predictors of subsequent functional
decline [6]
Higher stage breast cancer (p = 0.02) and weakness at time of diagnosis (p = 0.04)
were significantly associated with FS decline [5]
Pre-operative declines in ADL and cognitive impairment prior to surgery were
significantly linked to deteriorating functional trajectories at 1 year in breast cancer
patients who underwent a lumpectomy, mastectomy and ALND [9]
Examples of UK-based
prospective studies
Bridging the age gap
Phase 1 showed that older patients (70–95 years) undergoing breast cancer surgery
experienced a long-term negative impact on QOL and independence up to 2 years
[14]
For ER? breast cancer, patients who underwent either S?ET or PET both exhibited
a decline in global health status scores, with a sharper decline in the surgery group at
6 weeks and failure to return baseline [1]
Nottingham Research Programme
Updated findings were conflicting, showing areas of improvement related to FS and a
decline in others. No clear pattern was identified [16]
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ALND. These women subsequently required
more physical therapy services than those
without arm-related issues (22% vs 6%,
p = 0.0001). These findings were supported by
Tang et al. [9] who reported that over one-third
of women experienced symptoms (pain and
reduced range of motion) which disrupted
upper body function 6 months following breast
surgery, irrespective of procedure type.
An observational study by Girotto et al. [11]
looked at the effects of breast reconstruction
(two-stage implant reconstruction, free or
pedicled myocutaneous flaps) post-mastectomy
on QOL outcomes in 316 patients aged 65–-
77 years. This was measured using the self-re-
ported 36-Item Short Form Health Survey (SF-
36), which is scored between 0 and 100 (0 being
equivalent to maximum disability, 100 being
equivalent to no disability). Older women
(65–77 years) exhibited poorer outcomes in
physical function compared to younger women
(25–64 years). However, they demonstrated
higher scores than the younger group when
comparing social functioning and mental
health outcomes, which is likely attributable to
the psychological benefits associated with an
improvement in self-image succeeding recon-
structive surgery.
Given the adverse impact that different types
of breast cancer surgery have on older patients’
QOL, careful consideration of patient prefer-
ences, life expectancy and predicted survival
benefits should be weighed when making deci-




In addition to the impact of breast cancer sur-
gery on FS, various co-existing patient factors
can also act as possible predictors of subsequent
functional decline. These include advanced age,
multiple comorbidities, obesity, lower educa-
tional attainment and smoking [6, 7]. Singh
et al. [5] describe functional decline as an
increase of at least one point on the Eastern
Cooperative Oncology Group (ECOG) score
within one year of breast cancer diagnosis. Their
study reported that higher stage disease
(p = 0.02) and feeling of physical weakness
Table 1 continued
Current evidence
Potential for intervention Geriatric assessments
GAs aid in identifying health deficits that can potentially be optimised pre- or post-
operatively. They may also predict life expectancy and tolerance to oncological
treatments [2, 18]
Updated recommendations regarding the use of GAs to guide oncology treatment
were published in 2021 [2]
Screening tools can be used prior to a full GA due to time constraints [20]
It is feasible to develop and utilise a cancer-specific GA in clinical practice [18]
Exercise interventions
Two RCTs demonstrated the positive effects of exercise interventions on improving
physical function in breast cancer patients [21, 22]
ADL activities of daily living, ALND axillary lymph node dissection, BCSS breast cancer-specific survival, DESI decision
support instruments, ER? oestrogen receptor-positive, FS functional status, GA geriatric assessment, IADL instrumental
activities of daily living, PET primary endocrine therapy, QOL quality of life, RCT randomised controlled trial, S?ET
surgery with endocrine therapy, SIOG International Society of Geriatric Oncology, TUG timed up-and-go
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(p = 0.04) at time of diagnosis were significantly
linked to subsequent FS decline.
Nursing home residents in the study by Tang
et al. [9] were described as being cognitively
impaired if they (1) had a pre-existing diagnosis
of dementia; (2) were diagnosed with dementia
on their Minimum Data Set (MDS) assessment;
or (3) were measured as cognitively impaired
with the MDS Cognitive Performance Scale
(CPS) or Brief Interview of Mental Status (BIMS).
It was noted that pre-operative declines in ADL
(increase of C 2 points on the MDS-ADL score)
and cognitive impairment prior to surgery were
significantly associated with further deteriora-
tions in both these domains at 1 year following
breast cancer surgery (ALND, lumpectomy or
mastectomy).
This interplay between pre-existing comor-
bidities and baseline function on subsequent FS
decline in older cancer patients has highlighted
the importance of recognising such comorbidi-
ties in a timely manner, optimising them where
feasible and individualising oncological treat-
ment regimens as appropriate.
EXAMPLES OF UK-BASED
PROSPECTIVE STUDIES
Much of the current evidence looking at FS in
older patients after breast cancer surgery as
discussed thus far are retrospective in nature
and individually examine smaller cohorts of
patients. Two studies have been highlighted
here due to their contribution in strengthening
the evidence base in this area.
Bridging the Age Gap (BTAG)
The BTAG study [13] was a multicentre UK
study with two phases. Phase 1 was a prospec-
tive observational cohort study conducted from
2013 to 2018, that recruited 3375 patients
across 57 different sites. It aimed to investigate
breast cancer management in older women and
narrow the gap in their treatment outcomes
compared to younger women. Phase 1 out-
comes demonstrated that older patients
between 70 and 95 years (median 76)
undergoing breast cancer surgery experienced a
long-term negative impact on their QOL and
independence when followed up for 2 years
[14]. Phase 2 [13, 15] was a cluster-randomised
controlled trial nested within the larger BTAG
cohort study and aimed to evaluate the use of
clinical predictive tools and decision support
instruments (DESIs) in clinical decision-making
in older women with breast cancer.
In addition, BTAG examined the survival
outcomes and QOL in women aged 69–102
(median age 77) with operable ER? breast can-
cer following either surgery with endocrine
therapy (S?ET) or PET; the median follow-up
was 52 months. With regard to post-treatment
QOL and functional independence, both arms
exhibited a decline in their global health status
scores; nonetheless, the decline was sharper in
the surgery group 6 weeks from baseline,
demonstrating its acute impact on older
patients. Moreover, this score failed to return to
baseline level, highlighting its long-term effects
on FS [1].
Moving forward, these findings along with a
validated clinical predictive tool (https://
agegap.shef.ac.uk/) can help individualise
breast cancer treatment selection by enabling
shared decision-making between clinicians and
their patients.
Nottingham Research Programme
on Primary Breast Cancer in Older Women
A prospective pilot study [16] is currently being
conducted in the Nottingham area. Patient
recruitment commenced in 2009 and invites
women aged C 70 years with early-stage opera-
ble primary breast cancer to participate. The
aim is to examine the value of using a validated
cancer-specific comprehensive geriatric assess-
ment (CGA) [17] to assess older patients
undergoing surgery versus non-operative treat-
ment. The CGA is performed within 6 weeks
and 6 months post-diagnosis, supplemented
with the European Organisation for Research
and Treatment of Cancer Quality of Life of
Cancer Patients (EORTC QLQ C-30) and breast
cancer-specific (BR23) questionnaires as formal
measures of QOL.
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The most recent findings presented at the
International Society of Geriatric Oncology
(SIOG) 2019 annual conference reported results
from 88 women who underwent surgery [18].
Results were conflicting in that there was an
improvement in some questions related to FS
and a decline in others, with no clear pattern.
Results remained conflicted even when taking
into consideration intensity of surgery.
Although this study has demonstrated some
evidence to date indicating a decline in certain
aspects of FS following breast cancer surgery,
further research into the subject is required to
provide more concrete conclusions to guide
future treatment strategies. This study is cur-
rently ongoing and involves several centres
across the UK and Hong Kong [19], with the aim
of recruiting over 1000 patients.
POTENTIAL FOR INTERVENTION
Increasing awareness that FS may decline after
breast cancer surgery is the first step in high-
lighting the need for solutions to overcome it.
Relevant assessments along with timely inter-
ventions can help improve FS in older patients
following breast surgery. The validity of utilis-
ing GAs in older cancer patients has been
demonstrated and represents an area of ongoing
research [2, 16, 18]. One example of a strategic
intervention to improve physical functioning
following concerns identified with a GA
includes exercise interventions, which will be
discussed below. Figure 1 demonstrates poten-
tial areas for intervention in older women
undergoing breast cancer surgery.
Geriatric Assessment
Most recently, the European Society of Breast
Cancer Specialists (EUSOMA) and SIOG pub-
lished updated recommendations [2] on the
management of older patients with breast can-
cer. Routine use of GAs to guide oncology
treatment decisions in older patients was
advocated. Geriatric assessments aid in under-
standing older patients’ overall health status
and may predict life expectancy and tolerance
to treatments. Given that this population
comprises a physiologically heterogenous
group, the GA serves as a useful pre-operative
adjunct in differentiating between fit suscepti-
ble and frail older individuals, allowing for the
appropriate adjustments to treatment strategies.
A study by Hurria et al. [17] looked at the
feasibility of developing a cancer-specific GA
that meets the needs of the oncology commu-
nity. They focused on the essential domains
that are critical in assessing cancer patients,
such as FS, comorbidities, cognition, psycho-
logical health, nutrition, social functioning and
support. This study was valuable as it high-
lighted the difference in assessment goals
between the oncology and geriatric specialties; a
standard GA performed by a geriatrician may
take up to 2 hours, whilst not precisely
addressing the specific needs of oncologists who
require a more concise tool to identify the
subset of older patients whose limited physio-
logical reserves render them unsuitable for more
rigorous treatment regimes. The CGA proposed
here was primarily self-administered and brief,
requiring a mean time of 27 minutes to com-
plete. As mentioned above, the Nottingham














Fig. 1 Examples of areas for pre- and post-operative
intervention to help improve FS in older patients
following breast surgery
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feasibility of conducting a CGA in the research
setting.
In summary, the use of a pre-operative GA in
cancer patients is evidently valuable; however,
there is a lack of consensus regarding a stan-
dardised assessment measure, with multiple
different models available [2, 17]. Moreover,
due to time and resource constraints, a full GA
is not always practical in the clinical setting.
The latest SIOG guidelines [2] suggest that a
screening tool should be employed as a mini-
mum; in practice, this will allow for quick
identification of patients aged C 70 years with
potential frailties that warrant further system-
atic evaluation. Numerous screening tools
exists, but the highest sensitivity has been
observed with the use of the G8, Flemish ver-
sion of the Triage Risk Screening Tool (TRST),
Oncogeriatric screen, Study of Osteoporotic
Fractures, Eastern Cooperative Oncology
Group-Performance Status and Senior Adult
Oncology Program (SAOP) 2 screening, as
reported by Decoster et al. [20].
Therefore, moving forward, both screening
tools and GAs should be used in combination
given their complementary functions in iden-
tifying potentially optimisable health issues
that can be acted on pre- and post-operatively
with appropriate strategies.
Exercise Interventions
Exercise interventions represent a well-studied
area with evidence supporting the use of pre-
scribed physical activity to recover function in
older patients following breast cancer surgery
[21, 22].
Arrieta et al. [21] conducted a randomised
controlled trial (RCT) in cancer patients
aged C 70 years undergoing curative treatment
(surgery, chemotherapy, radiotherapy). The
study was divided into two arms, with 301
participants distributed between the usual care
group (UCG) who received national recom-
mendations on physical activity, and the inter-
vention group (IG), who received individually
tailored physical activity advice for 1 year.
Functional decline was defined as a drop in C 1
point in the short physical performance (SPPB)
score. Breast represented the most frequent
tumour site in this study (35.7%). After 2 years,
a decline in SPPB of 29.8% in the UCG and 5%
in the IG group was noted amongst breast can-
cer participants (p = 0.006), demonstrating an
effective slowing in physical decline; however,
similar encouraging results were not observed
after 1 year (p = 0.119).
Next, the RESTORE RCT by Anderson et al.
[22] examined the effectiveness of a moderate,
tailored exercise intervention compared to
usual care (patient education) on physical
function, health-related QOL (HRQOL) and arm
volume in women with newly diagnosed stage
I–III breast cancer receiving treatment. A total
of 104 patients were randomised into two arms
within 4–12 weeks post-surgery and followed up
for 18 months. It was noted that 46% of par-
ticipants underwent breast-conserving surgery,
79% had axillary node dissection, 59% received
chemotherapy and 64% radiotherapy. Physical
function was assessed with the 6-minute walk
test (6MWT) and HRQOL with the Functional
Assessment of Cancer Therapy–Breast Cancer
(FACT-B). Results showed that patients receiv-
ing exercise interventions demonstrated a sig-
nificant increase in physical function, with a
longer distance walked (593.2 m vs 558.9 m;
p = 0.0098) for the 6MWT compared to the
usual care arm. Nonetheless, there was no sig-
nificant effect on FACT-B scores for HRQOL and
arm volume.
Given the evidence that exists regarding the
value in utilising GAs and exercise programmes
in older cancer patients, these areas of assess-
ment and subsequent intervention should be
adopted in clinical practice to allow for opti-
misation of patients’ pre- and post-treatment
function. Other types of interventions include
the Enhanced Recovery after Surgery (ERAS)
pathway, pre-habilitation nutritional support,
active chest physiotherapy and psychological
support [3]. These areas are beyond the scope of
discussion of this article but have been covered
in a full systematic review of the subject by
Harrison et al. [6].
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CONCLUSION
There is limited evidence regarding FS outcomes
after breast cancer surgery in older patients;
however, from the evidence available, there
does appear to be a degree of decline in FS post-
operatively, and this decline appears to be
related to the intensity of surgery.
Notably, the interaction between breast
cancer surgery and co-existing comorbidities
may result in the overall survival benefits being
limited in more frail women. It has been noted
that patients place as much importance on their
QOL as their length of life [7]. Therefore, a more
tailored approach to the decision-making pro-
cess surrounding breast cancer treatment
should be adopted, as older patients represent a
physiologically heterogenous group where
treatment planning should not be determined
based on chronological age alone.
Examples of areas for intervention have been
highlighted in this review, such as the use of a
pre-operative GA in older cancer patients to
assess for fitness for treatment. In addition, the
incorporation of exercise programmes should
also be considered, to allow for patient optimi-
sation and improved functional recovery where
possible. Other interventions such as nutri-
tional and psychological support, as well as the
established ERAS pathway, can also be explored.
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